ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse] 김새미 2026.02.02 오전 08:10 2% Royalty Shock at Alteogen Ripples Through Korean Biotech[K-Bio Pulse] 김새미 2026.01.22 오전 08:00 ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 김새미 2025.11.12 오후 06:05 ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse] 김진수 2025.04.08 오전 07:58 [임상 업데이트] 유한양행, 면역 항암 신약 임상 1·2상 승인 김진수 2025.04.12 오후 01:51 Biotech Rallies as Four Firms Join Korea’s Top 10 Stock Gainers[K-Bio Pulse] 유진희 2025.05.28 오전 07:48 Peptron Jumps on Lilly Hopes; CORESTEMCHEMON Falls on Rights Issue[K-Bio Pulse] 김새미 2025.11.21 오전 08:50 [에이비엘바이오 대해부]③“빅파마 대상 기술수출 계속 타진할 것” 김진호 2022.01.19 오전 07:50 CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 김진수 2025.03.27 오전 08:29 Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse] 송영두 2025.04.03 오전 08:08 더 보기 로딩중..
ABLBio
ABLBio
![ABL Bio Slides on Sanofi Reprioritization...Stock Specific Risks Hit Biotechs[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/02/PS26020200188b.jpg)
![2% Royalty Shock at Alteogen Ripples Through Korean Biotech[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/01/PS26012200181b.jpg)
![ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25111201284b.jpg)
![ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040800208b.jpg)
![[임상 업데이트] 유한양행, 면역 항암 신약 임상 1·2상 승인](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25041200245b.jpg)
![Biotech Rallies as Four Firms Join Korea’s Top 10 Stock Gainers[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/05/PS25052800264b.jpg)
![Peptron Jumps on Lilly Hopes; CORESTEMCHEMON Falls on Rights Issue[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25112100378b.jpg)
![[에이비엘바이오 대해부]③“빅파마 대상 기술수출 계속 타진할 것”](https://image.edaily.co.kr/images/photo/files/NP/S/2022/07/PS22071800537b.jpg)
![CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032700436b.jpg)
![Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040300289b.jpg)